Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 2 boards, counting each seat separately. Longest: Neuropace Inc., 3 years.
Neuropace Inc.
Director
Amanat Acquisition Corp
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 19, 2026 | Neuropace Inc. | Grant or award | +989 | $15.63 | $15,458 |
| Jun 5, 2026 | Neuropace Inc. | Grant or award | +2,890 | — | — |
| Mar 20, 2026 | Neuropace Inc. | Grant or award | +1,153 | $13.00 | $14,989 |
| Dec 19, 2025 | Neuropace Inc. | Grant or award | +904 | $16.59 | $14,997 |
| Sep 19, 2025 | Neuropace Inc. | Grant or award | +1,509 | $9.94 | $14,999 |
| Jun 21, 2025 | Neuropace Inc. | Grant or award | +1,440 | $10.41 | $14,990 |
| Mar 21, 2025 | Neuropace Inc. | Grant or award | +1,247 | $12.02 | $14,989 |
| Feb 20, 2025 | Roivant Sciences Ltd. | Shares withheld for tax | −958 | $10.72 | $10,270 |
| Feb 13, 2025 | Roivant Sciences Ltd. | Option exercise | +187,500 | $3.85 | $721,875 |
| Feb 13, 2025 | Roivant Sciences Ltd. | Open-market sale | −227,500 | $10.43 | $2,372,825 |
| Jan 20, 2025 | Roivant Sciences Ltd. | Shares withheld for tax | −1,057 | $11.15 | $11,786 |
| Dec 21, 2024 | Neuropace Inc. | Grant or award | +1,300 | $11.53 | $14,989 |
| Dec 20, 2024 | Roivant Sciences Ltd. | Shares withheld for tax | −3,087 | $11.57 | $35,717 |
| Nov 20, 2024 | Roivant Sciences Ltd. | Shares withheld for tax | −958 | $11.49 | $11,007 |
| Oct 20, 2024 | Roivant Sciences Ltd. | Shares withheld for tax | −956 | $11.92 | $11,396 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.